Biological properties of tocotrienols: Evidence in human studies

International Journal of Molecular Sciences

Volumn 17, Issue 11, 2016, Pages

  Meganathan, Puvaneswari ^a   Fu, Ju Yen ^a  

^a MALAYSIAN PALM OIL BOARD   (Malaysia)

Author keywords

Biological properties; Clinical trial; Human studies; Palm oil; Tocotrienols

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CHOLESTEROL; GAMMA TOCOTRIENOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAMOXIFEN; TOCOTRIENOL RICH FRACTION; TOCOTRIENOL RICH VITAMIN E; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; IMMUNOLOGIC FACTOR; NEUROPROTECTIVE AGENT; RADIOPROTECTIVE AGENT; VITAMIN;

AGE; BREAST CANCER; CANCER RECURRENCE; CARDIOVASCULAR RISK; COGNITION; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; IMMUNOMODULATION; MATERNAL HYPERTENSION; NEUROPROTECTION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SKIN PROTECTION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASES; DRUG EFFECTS; NEOPLASMS;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; COGNITION; HUMANS; IMMUNOLOGIC FACTORS; NEOPLASMS; NEUROPROTECTIVE AGENTS; RADIATION-PROTECTIVE AGENTS; TOCOTRIENOLS; VITAMINS;

EID: 84994030074     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17111682     Document Type: Review

References (49)

1. Frost and Sullivan. Global Nutraceutical Industry: Investing in Healthy Living. Available online: www.frost. com/prod/servlet/cio/236145272 (accessed on 15 June 2016).
2. Kannappan, R.; Gupta, S.C.; Kim, J.H.; Aggarwal, B.B. Tocotrienols fight cancer by targeting multiple cell signaling pathways. Genes Nutr. 2012, 7, 43-52. [CrossRef] [PubMed]
3. Miller, E.R.; Pastor-Barriuso, R.; Dalal, D.; Riemersma, R.A.; Appel, L.J.; Guallar, E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142, 37-46. [CrossRef] [PubMed]
4. Meydani, M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J. Nutr. 2001, 131, 366S-368S. [PubMed]
5. Parker, R.A.; Pearce, B.C.; Clark, R.W.; Gordon, D.A.; Wright, J.J. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 1993, 268, 11230-11238. [PubMed]
6. Khor, H.T.; Chieng, D.Y.; Ong, K.K. Tocotrienols inhibit liver HMG CoA reductase activity in the guinea pig. Nutr. Res. 1995, 15, 537-544. [CrossRef]
7. Qureshi, A.A.; Qureshi, N.;Wright, J.J.; Shen, Z.; Kramer, G.; Gapor, A.; Chong, Y.H.; deWitt, G.; Ong, A.S.H.; Peterson, D.M. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 1991, 53, 1021S-1026S. [PubMed]
8. Qureshi, A.A.; Bradlow, B.A.; Salser, W.A.; Brace, L.D. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J. Nutr. Biochem. 1997, 8, 290-298. [CrossRef]
9. Qureshi, A.A.; Sami, S.A.; Salser,W.A.; Khan, F.A. Synergistic effect of tocotrienol-rich fraction (TRF 25) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J. Nutr. Biochem. 2001, 12, 318-329. [CrossRef]
10. Qureshi, A.A.; Sami, S.A.; Salser, W.A.; Khan, F.A. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF 25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002, 161, 199-207. [CrossRef]
11. Yuen, K.H.; Wong, J.W.; Lim, A.B.; Ng, B.H.; Choy, W.P. Effect of mixed-tocotrienols in hypercholesterolemic subjects. Funct. Food Health Dis. 2011, 1, 106-117.
12. Wahlqvist, M.L.; Krivokuca-Bogetic, Z.; Lo, C.S.; Hage, B.; Smith, R.; Lukito, W. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without change in coronary risk factors. Nutr. Res. 1992, 12, S181-S201. [CrossRef]
13. Mensink, R.P.; van Houwelingen, A.C.; Kromhout, D.; Hornstra, G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr. 1999, 69, 213-219. [PubMed]
14. Rasool, A.H.; Yuen, K.H.; Yusoff, K.; Wong, A.R.; Rahman, A.R. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J. Nutr. Sci. Vitaminol. 2006, 52, 473-478. [CrossRef] [PubMed]
15. Rasool, A.H.G.; Rahman, A.R.A.; Yuen, K.H.;Wong, A.R. Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E. Arch. Pharmacal Res. 2008, 31, 1212-1217. [CrossRef] [PubMed]
16. Chin, S.F.; Ibahim, J.; Makpol, S.; Hamid, N.A.A.; Latiff, A.A.; Zakaria, Z.; Mazlan, M.; Yusof, Y.A.M.; Karim, A.A.; Ngah, W.Z.W. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study. Nutr. Metab. 2011. [CrossRef] [PubMed]
17. Tan, D.T.; Khor, H.T.; Low,W.H.; Ali, A.; Gapor, A. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am. J. Clin. Nutr. 1991, 53, 1027S-1030S. [PubMed]
18. Baliarsingh, S.; Beg, Z.H.; Ahmad, J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005, 182, 367-374. [CrossRef] [PubMed]
19. Daud, Z.A.M.; Tubie, B.; Sheyman, M.; Osia, R.; Adams, J.; Tubie, S.; Khosla, P. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc. Health Risk Manag. 2013, 9, 747-761. [PubMed]
20. Tomeo, A.C.; Geller, M.;Watkins, T.R.; Gapor, A.; Bierenbaum, M.L. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 1995, 30, 1179-1183. [CrossRef] [PubMed]
21. Lim, S.W.; Loh, H.S.; Ting, K.N.; Bradshaw, T.D.; Zeenathul, N.A. Cytotoxicity and apoptotic activities of α-, β-and δ-tocotrienol isomers on human cancer cells. BMC Complement. Altern. Med. 2014. [CrossRef] [PubMed]
22. Khanna, S.; Parinandi, N.L.; Kotha, S.R.; Roy, S.; Rink, C.; Bibus, D.; Sen, C.K. Nanomolar vitamin E α-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection. J. Neurochem. 2010, 112, 1249-1260. [CrossRef] [PubMed]
23. Mustad, V.A.; Smith, C.A.; Ruey, P.P.; Edens, N.K.; DeMichele, S.J. Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am. J. Clin. Nutr. 2002, 76, 1237-1243. [PubMed]
24. Zaiden, N.; Yap, W.N.; Ong, S.; Xu, C.H.; Teo, V.H.; Chang, C.P.; Zhang, X.W.; Nesaretnam, K.; Shiba, S.; Yap, Y.L. Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. J. Atheroscler Thromb. 2010, 17, 1019-1032. [CrossRef] [PubMed]
25. O’Byrne, D.; Grundy, S.; Packer, L.; Devaraj, S.; Baldenius, K.; Hoppe, P.P.; Kraemer, K.; Jialal, I.; Traber, M.G. Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radic. Biol. Med. 2000, 29, 834-845. [CrossRef]
26. Nesaretnam, K.; Meganathan, P.; Veerasenan, S.D.; Selvaduray, K.R. Tocotrienols and breast cancer: The evidence to date. Genes Nutr. 2012, 7, 3-9. [CrossRef] [PubMed]
27. Nesaretnam, K.; Selvaduray, K.R.; Razak, G.A.; Veerasenan, S.D.; Gomez, P.A. Effectiveness of tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast cancer: A pilot clinical trial. Breast Cancer Res. 2010. [CrossRef] [PubMed]
28. Springett, G.M.; Husain, K.; Neuger, A.; Centeno, B.; Chen, D.T.; Hutchinson, T.Z.; Lush, R.M.; Sebti, S.; Malafa, M.P. A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E α-tocotrienol in Patients with Pancreatic Ductal Neoplasia. EBioMedicine 2015, 2, 1987-1995. [CrossRef] [PubMed]
29. Radhakrishnan, A.K.; Lee, A.L.;Wong, P.F.; Kaur, J.; Aung, H.; Nesaretnam, K. Daily supplementation of tocotrienol-rich fraction or α-tocopherol did not induce immunomodulatory changes in healthy human volunteers. Br. J. Nutr. 2009, 101, 810-815. [CrossRef] [PubMed]
30. Mahalingam, D.; Radhakrishnan, A.K.; Amom, Z.; Ibrahim, N.; Nesaretnam, K. Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers. Eur. J. Clin. Nutr. 2011, 65, 63-69. [CrossRef] [PubMed]
31. Jubri, Z.; Latif, A.A.; Top, A.G.M.; Ngah, W.Z.W. Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation. J. Nutr. 2013. [CrossRef] [PubMed]
32. Patel, V.; Rink, C.; Gordillo, G.M.; Khanna, S.; Gnyawali, U.; Roy, S.; Shneker, B.; Ganesh, K.; Phillips, G.; More, J.L.; et al. Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. J. Nutr. 2012, 142, 513-519. [CrossRef] [PubMed]
33. Gopalan, Y.; Shuaib, I.L.; Magosso, E.; Ansari, M.A.; Bakar, M.R.A.;Wong, J.W.; Khan, N.A.K.; Liong,W.C.; Sundram, K.; Ng, B.H.; et al. Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter. Stroke 2014, 45, 1422-1428. [CrossRef] [PubMed]
34. Tan, M.L.; Foong, S.C.; Foong, W.C.; Yusuff, Y.; Chettiar, S.M. Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): A randomized controlled trial. BMC Nutr. 2016. [CrossRef]
35. Pedrelli, V.F.; Lauriola, M.M.; Pigatto, P.D. Clinical evaluation of photoprotective effect by a topical antioxidants combination (tocopherols and tocotrienols). J. Eur. Acad. Dermatol. Venereol. 2012, 26, 1449-1453. [CrossRef] [PubMed]
36. Khoo, T.L.; Halim, A.S.; Zakaria, Z.; Saad, A.M.; Wu, L.Y.; Lau, H.Y. A prospective, randomised, double-blinded trial to study the efficacy of topical tocotrienol in the prevention of hypertrophic scars. J. Plast Reconstr. Aesthet. Surg. 2011, 64, e137-e145. [CrossRef] [PubMed]
37. Heng, E.C.; Karsani, S.A.; Rahman, M.A.; Hamid, N.A.A.; Hamid, Z.; Ngah, W.Z.W. Supplementation with tocotrienol-rich fraction alters the plasma levels of Apolipoprotein AI precursor, Apolipoprotein E precursor, and C-reactive protein precursor from young and old individuals. Eur. J. Nutr. 2013, 52, 1811-1820. [CrossRef] [PubMed]
38. ® Tocotrienol supplementation. Nutrition 2008, 24, 1-10. [CrossRef] [PubMed]
39. Magosso, E.; Ansari, M.A.; Gopalan, Y.; Shuaib, I.L.; Wong, J.W.; Khan, N.A.K.; Bakar, M.R.A.; Ng, B.H.; Yuen, K.H. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: A randomised placebo-controlled clinical trial. Nutr. J. 2013. [CrossRef] [PubMed]
40. Gan, Y.L.; Ming, L.; How, C.B.; Hay, Y.K.; Nesaretnam, K.; Kim-Tiu, T.; Selvaduray, K.R.; Meganathan, P.; Fu, J.-Y. Safety assessment of tocotrienol supplementation in subjects with metabolic syndrome: A randomised control trial. J. Oil Palm Res. 2016, 28, 34-43.
41. Mahdy, Z.A.; Siraj, H.H.; Khaza’ai, H.; Mutalib, M.S.A.; Azwar, M.H.; Wahab, M.A.; Dali, A.Z.H.M.; Jaafar, R.; Ismail, N.A.M.; Jamil, M.A.; et al. Does palm oil vitamin E reduce the risk of pregnancy induced hypertension? Acta Medica 2013, 56, 104-109. [CrossRef] [PubMed]
42. Yap, S.P.; Yuen, K.H.; Wong, J.W. Pharmacokinetics and bioavailability of α-, γ-and δ-tocotrienols under different food status. J. Pharm. Pharmacol. 2001, 53, 67-71. [CrossRef] [PubMed]
43. Yap, S.P.; Yuen, K.H. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int. J. Pharm. 2004, 281, 67-78. [CrossRef] [PubMed]
44. Fairus, S.; Nor, R.M.; Cheng, H.M.; Sundram, K. Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α-tocopherol. Am. J. Clin. Nutr. 2006, 84, 835-842. [PubMed]
45. Fairus, S.; Nor, R.M.; Cheng, H.M.; Sundram, K. α-tocotrienol is the most abundant tocotrienol isomer circulated in plasma and lipoproteins after postprandial tocotrienol-rich vitamin E supplementation. Nutr. J. 2012. [CrossRef] [PubMed]
46. Loganathan, R.; Selvaduray, K.R.; Nesaretnam, K.; Radhakrishnan, A.K. Tocotrienols promote apoptosis in human breast cancer cells by inducing poly (ADP-ribose) polymerase cleavage and inhibiting nuclear factor κ-B activity. Cell Prolif. 2013, 46, 203-213. [CrossRef] [PubMed]
47. Selvaduray, K.R.; Radhakrishnan, A.K.; Kutty, M.K.; Nesaretnam, K. Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells. Genes Nutr. 2012, 7, 53-61. [CrossRef] [PubMed]
48. Meganathan, P.; Jabir, R.S.; Fuang, H.G.; Bhoo-Pathy, N.; Choudhury, R.B.; Taib, N.A.; Nesaretnam, K.; Chik, Z. A new formulation of gamma delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects. Sci. Rep. 2015. [CrossRef] [PubMed]
49. Fu, J.-Y.; Che, H.L.; Tan, D.M.Y.; Teng, K.T. Bioavailability of tocotrienols: Evidence in human studies. Nutr. Metab. 2014. [CrossRef] [PubMed]